Altimmune (ALT) Notes Payables (2012 - 2020)
Altimmune (ALT) posted quarterly Notes Payables of $632000.0 for Q2 2020, up 286.02% year-over-year from $163724.0 in Q3 2019, and up 501.55% quarter-over-quarter from $105062.0 in Q3 2019.
Powered by 
Analysis
Altimmune (ALT) Notes Payables (2012 - 2020) Analysis & Trends
Altimmune (ALT) has reported Notes Payables for 7 consecutive years, with $632000.0 the latest figure, recorded in Q2 2020.
- In Q2 2020, Notes Payables rose 286.02% year-over-year to $632000.0; the TTM figure through Jun 2020 stood at $632000.0 (up 286.02% YoY), while the FY2018 annual figure was $71596.0, up 44.05% from the prior year.
- Notes Payables advanced to $632000.0 in Q2 2020 per ALT's latest filing, from $105062.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.5 million in Q3 2018 and bottomed at $49702.0 in Q2 2017.
- Historically, Notes Payables has averaged $386259.6 across 5 years, with a median of $134393.0 in 2019.
- Annual changes were most pronounced in 2018 — Notes Payables soared 2852.11% — and 2019, when it slumped 92.84%.
- Altimmune's Notes Payables stood at $458629.0 in 2016, then sank by 89.16% to $49702.0 in 2017, then surged by 44.05% to $71596.0 in 2018, then surged by 46.74% to $105062.0 in 2019, then surged by 501.55% to $632000.0 in 2020.
- Business Quant data shows ALT's Notes Payables at $632000.0 in Q2 2020, $105062.0 in Q3 2019, and $163724.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Altimmune | 636.07 Mn | 636.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 632,000.00 |
| Sep 30, 2019 | 105,062.00 |
| Jun 30, 2019 | 163,724.00 |
| Mar 31, 2019 | 227,117.00 |
| Dec 31, 2018 | 71,596.00 |
| Sep 30, 2018 | 1.47 Mn |
| Jun 30, 2018 | 1.31 Mn |
| Mar 31, 2018 | 49,702.00 |
| Dec 31, 2017 | 49,702.00 |
| Sep 30, 2017 | 49,702.00 |
| Jun 30, 2017 | 49,702.00 |
| Dec 31, 2016 | 458,629.00 |
| Dec 31, 2013 | 1.09 Mn |
| Jun 30, 2013 | 1.17 Mn |
| Mar 31, 2013 | 1.33 Mn |
| Dec 31, 2012 | 1.33 Mn |
| Sep 30, 2012 | 1.21 Mn |
| Mar 31, 2012 | 857,808.00 |